Merck (MRK) Net Income (2009 - 2026)

Merck (MRK) posted quarterly Net Income of -$4.2 billion for Q1 2026, down 182.77% YoY from $5.1 billion in Q1 2025, and down 242.1% sequentially from $3.0 billion in Q4 2025.

Merck (MRK) Net Income (2009 - 2026) Analysis & Trends

Merck has disclosed Net Income across 17 years of filings, most recently posting -$4.2 billion for Q1 2026.

  • In Q1 2026, Net Income fell 182.77% year-over-year to -$4.2 billion; the TTM figure through Mar 2026 stood at $9.0 billion (down 48.61% YoY), while the FY2025 annual figure was $18.3 billion, up 6.6% from the prior year.
  • Net Income declined to -$4.2 billion in Q1 2026, from $3.0 billion in the prior quarter.
  • Over the last five years, Net Income for MRK reached as high as $5.8 billion in Q3 2025 and fell as low as -$5.9 billion in Q2 2023.
  • The 4-year median for Net Income is $3.7 billion (2024), against an average of $2.4 billion.
  • Annual changes were most pronounced in 2024 — Net Income soared 405.38% — and 2026, when it plunged 182.77%.
  • A 4-year view of Net Income shows it stood at -$1.2 billion in 2023, then soared by 405.38% to $3.7 billion in 2024, then decreased by 20.89% to $3.0 billion in 2025, then slumped by 242.1% to -$4.2 billion in 2026.
  • According to Business Quant data, Net Income over the past three periods registered -$4.2 billion, $3.0 billion, and $5.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.40 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 5.24 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 697.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 833.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -4.21 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.02 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -13.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 319.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.21 Bn
Dec 31, 2025 2.96 Bn
Sep 30, 2025 5.79 Bn
Jun 30, 2025 4.43 Bn
Mar 31, 2025 5.09 Bn
Dec 31, 2024 3.74 Bn
Sep 30, 2024 3.16 Bn
Jun 30, 2024 5.46 Bn
Mar 31, 2024 4.77 Bn
Dec 31, 2023 -1.23 Bn
Sep 30, 2023 4.75 Bn
Jun 30, 2023 -5.94 Bn
Mar 31, 2023 2.83 Bn
Dec 31, 2021 -62.00 Mn
Jun 30, 2021 332.00 Mn
Mar 31, 2021 437.00 Mn
Dec 31, 2020 523.00 Mn
Sep 30, 2020 617.00 Mn
Jun 30, 2020 661.00 Mn
Mar 31, 2020 3.22 Bn